 | Anticancer drugs: design, delivery and pharmacology / ed. by P.Spencer, W.Holt. - New York: Nova Biomedical Books, 2009. - xi, 271 p.: ill. - (Cancer Etiology, Diagnosis and Treatments). - Bibliogr. at the end of the chapters. - Ind.: p.249-271. - ISBN-10 1-60741-004-4; ISBN-13 978-1-60741-004-1
|
Preface ....................................................... vii
Research and Review Studies
Chapter I Micro- and Nano-Particulate Drug Delivery
Systems for Cancer Treatment ....................... 1
José L. Arias
Chapter II Geldanamycin Derivatives as Promising Anticancer
Drugs: Therapy via Hsp90 Inhibition ............... 87
Alexander E. Kabakov
Chapter III Synergistic Antitumor Activity of Metronomic
Dosing Chemotherapy in Combination with
Liposomal Anticancer Drug ........................ 115
Tatsuhiro Ishida and Hiroshi Kiwada
Chapter IV Organotin Polyethers as Anticancer Drugs ......... 145
Charles E. Carraher, Michael R. Roner and
Girish Barot
Chapter V Studies on Anti-Cancer Agents: Phenolic
Compounds and Their Pharmacological Activity ..... 171
Maria Dolors Pujol and Isabel Sánchez
Chapter VI Design of Novel Anticancer Drugs Utilizing
Busulfan for Optimizing Pharmacological
Properties and Pattern Recognition Techniques
for Elucidation of Clinical Efficacy ............. 195
Ronald Bartzatt
Chapter VII Analysis of Associations among Novel Property
Descriptors and Their Capacity in Determining
Clinical Efficacy by Utilizing Pattern
Recognition Techniques ........................... 211
Ronald Bartzatt
Chapter VIII Insights into the Mode of Action of
Bioreductive Ruthenium Cytotoxins ................ 227
Erwin Reisner
Short Communication ........................................... 239
Marina Crystal Minerals (MCM) Induce Apoptosis
of Human Metastatic Breast Cancer MDA-MB-231
Cells in vitro ................................... 239
Mamdooh Ghoneum, Takeshi Ogura and Sastry
Gollapudi
Index ......................................................... 249
|
|
